BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9507011)

  • 1. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
    Park ST; Sun XH
    J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
    Gould KA; Bresnick EH
    Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
    Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
    J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
    O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
    Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
    Ono Y; Fukuhara N; Yoshie O
    J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
    Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
    Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins.
    Doyle K; Zhang Y; Baer R; Bina M
    J Biol Chem; 1994 Apr; 269(16):12099-105. PubMed ID: 8163514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
    Goldfarb AN; Lewandowska K
    Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
    Hsu HL; Cheng JT; Chen Q; Baer R
    Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding properties of basic helix-loop-helix fusion proteins of Tal and E47.
    Ghosh I; Bishop P; Chmielewski J
    J Pept Res; 2001 May; 57(5):354-60. PubMed ID: 11350595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of E47-NeuroD1/beta2 bHLH domain-DNA complex: heterodimer selectivity and DNA recognition.
    Longo A; Guanga GP; Rose RB
    Biochemistry; 2008 Jan; 47(1):218-29. PubMed ID: 18069799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells.
    Liu Y; Encinas M; Comella JX; Aldea M; Gallego C
    Mol Cell Biol; 2004 Apr; 24(7):2662-72. PubMed ID: 15024057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-mediated folding and assembly of MyoD-E47 heterodimers.
    Wendt H; Thomas RM; Ellenberger T
    J Biol Chem; 1998 Mar; 273(10):5735-43. PubMed ID: 9488706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.